Qin Feng

机构：Fourth Affiliated Hospital of China Medical University · ORCID：0000-0003-3408-4938

发表论文 17 篇 · 总被引 241 次 · h-index 10

代表论文

• Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis (2024 · Metabolism · 被引 59)
• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 33)
• Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases (2022 · Frontiers in Pharmacology · 被引 28)
• The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD : A Systematic Review and Meta‐Analysis (2024 · Food Science & Nutrition · 被引 22)
• Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids (2022 · Frontiers in Cellular and Infection Microbiology · 被引 20)
• Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD (2022 · Frontiers in Pharmacology · 被引 18)